News

1 Day MLD.M 4.17% DJIA -1.18% Russell 2K -2.06% Real Estate/Construction -2.41% ...
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' When we think about how risky a company is, we always like ...
With strong execution in 2019 and a solid balance sheet heading into 2020, ... MLD: Data from a total of 33 patients treated with OTL-200, ...
Expected clinical package for OTL-200 BLA for MLD using data from existing patients clarified with FDA Guidance obtained on design of OTL-203 global registrational trial for MPS-IH Enrollment goal ...
Homology Medicines Presents Preclinical Data Supporting Immunosuppression Regimen in Ongoing PKU and Hunter Syndrome Clinical Trials, and Details Optimized MLD Gene Therapy Candidate at the 19th ...
--Homology Medicines, Inc., a genetic medicines company, announced today the presentation of preclinical data that support its investigational gene therapy programs for the treatment of ...
Expected clinical package for OTL-200 BLA for MLD using data from existing patients clarified with FDA Guidance obtained on design of OTL-203 global registrational trial for MPS-IH Enrollment goal met ...